Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
After a gay man tested HIV positive, a test of his hair indicated he’d adhered well to PrEP—but did he contract a drug-resistant strain?
The site already featured a data-rich map detailing the HIV epidemic.
Expanded services at the remodeled facility are part of the mayor’s Ending the Epidemic plan.
A new analysis broke down U.S. PrEP use by location and demographics and compared it with corresponding HIV diagnosis rates.
This is according to the world’s first study to conduct an analysis of PrEP’s apparent effect on the HIV rate on a public-health level.
Continuously providing such infants with antiretrovirals as early as possible limits the size of the reservoir.
Merck’s investigational antiretroviral could one day be dosed only weekly among humans.
Another gay man says he was denied PrEP while serving for the Peace Corps in Ukraine, where HIV rates are high.
The federal health agency has revised its estimates of how many U.S. residents would benefit from PrEP and provided more granular data.
The open-label follow-up to a previous placebo-controlled study of an HIV-preventing ring is seeing high use among women.
According to recent studies, this shift in risk is likely driven by biological, and not just behavioral, factors.
Truvada appeared to temporarily prevent some weight gain and reduce cholesterol slightly in a recent study.
Researchers are trying to harness the power of certain antibodies as long-acting injectable forms of HIV treatment or PrEP.
And yet those who don’t take the HIV prevention med can qualify for the policies.
The San Francisco campaign hopes to overcome racial disparities in HIV health.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.